Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stargray (Xi'an Stargray Biotechnology) is a specialized biotechnology company focused on the development and production of fluorescent labeling reagents and molecular probes for life science research. The company provides a comprehensive range of products, including Cyanine dyes (Cy3, Cy5, Cy7), Indocyanine Green (ICG) derivatives, BODIPY dyes, and fluorescent microspheres, with applications spanning from cellular imaging to near-infrared (NIR-II) in vivo imaging. Stargray also offers custom conjugation services, enabling the precise labeling of proteins, peptides, nucleic acids, and nanoparticles for advanced biomedical applications. Headquartered in Xi'an with additional R&D centers in Chongqing and Changsha, the company supports researchers in academia and the pharmaceutical industry with high-quality imaging tools and tailored chemical solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 星戈瑞.